⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 15, 2024

[Clinical efficacy of nusinersen sodium in the treatment of children with spinal muscular atrophy].

View Full Paper

Ask AI

Bookmark

Share

Abstract

To investigate the efficacy and safety of nusinersen sodium in the treatment of children with spinal muscular atrophy (SMA).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Guo et al. (2024) studied this question.

synapsesocial.com/papers/68e60559b6db643587598b2e https://doi.org/10.7499/j.issn.1008-8830.2401082

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Safety analysis of laboratory parameters in paediatric patients with spinal muscular atrophy treated with nusinersen2024
2Analysis of the efficacy and adverse effects of nusinersen in the treatment of children with spinal muscular atrophy in China2024 · 8 citations
3Effectiveness of Nusinersen in Adolescents and Adults with Spinal Muscular Atrophy: Systematic Review and Meta-analysis2024 · 30 citations
4Treatment of Symptomatic Spinal Muscular Atrophy with Nusinersen: A Prospective Longitudinal Study on Scoliosis Progression2024 · 14 citations
5Nusinersen effectiveness and safety in pediatric patients with 5q-spinal muscular atrophy: a multi-center disease registry in China2024 · 17 citations